These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 19850644

  • 21. Time-course comparison of xenobiotic activators of CAR and PPARalpha in mouse liver.
    Ross PK, Woods CG, Bradford BU, Kosyk O, Gatti DM, Cunningham ML, Rusyn I.
    Toxicol Appl Pharmacol; 2009 Mar 01; 235(2):199-207. PubMed ID: 19136022
    [Abstract] [Full Text] [Related]

  • 22. Evidence for the involvement of xenobiotic-responsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species.
    Ren H, Vallanat B, Nelson DM, Yeung LWY, Guruge KS, Lam PKS, Lehman-McKeeman LD, Corton JC.
    Reprod Toxicol; 2009 Jun 01; 27(3-4):266-277. PubMed ID: 19162173
    [Abstract] [Full Text] [Related]

  • 23. Regulation of hepatic xenosensor function by HNF4alpha.
    Kotulkar M, Paine-Cabrera D, Robarts DR, Apte U.
    Toxicol Sci; 2024 Aug 01; 200(2):346-356. PubMed ID: 38810120
    [Abstract] [Full Text] [Related]

  • 24. Quantitative proteomic analysis of mouse liver response to the peroxisome proliferator diethylhexylphthalate (DEHP).
    Macdonald N, Chevalier S, Tonge R, Davison M, Rowlinson R, Young J, Rayner S, Roberts R.
    Arch Toxicol; 2001 Sep 01; 75(7):415-24. PubMed ID: 11693183
    [Abstract] [Full Text] [Related]

  • 25. Functional role of phospholipase D (PLD) in di(2-ethylhexyl) phthalate-induced hepatotoxicity in Sprague-Dawley rats.
    Kim NY, Kim TH, Lee E, Patra N, Lee J, Shin MO, Kwack SJ, Park KL, Han SY, Kang TS, Kim SH, Lee BM, Kim HS.
    J Toxicol Environ Health A; 2010 Sep 01; 73(21-22):1560-9. PubMed ID: 20954081
    [Abstract] [Full Text] [Related]

  • 26. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor α and Peroxisome Proliferator-Activated Receptor γ Coactivator 1α-Dependent Gene Expression to Increase Blood Triglyceride Levels.
    Shizu R, Otsuka Y, Ezaki K, Ishii C, Arakawa S, Amaike Y, Abe T, Hosaka T, Sasaki T, Kanno Y, Miyata M, Yamazoe Y, Yoshinari K.
    Mol Pharmacol; 2020 Nov 01; 98(5):634-647. PubMed ID: 32892155
    [Abstract] [Full Text] [Related]

  • 27. Induction of peroxisome proliferator-activated receptor alpha (PPARalpha)-related enzymes by di(2-ethylhexyl) phthalate (DEHP) treatment in mice and rats, but not marmosets.
    Ito Y, Yamanoshita O, Kurata Y, Kamijima M, Aoyama T, Nakajima T.
    Arch Toxicol; 2007 Mar 01; 81(3):219-26. PubMed ID: 16937134
    [Abstract] [Full Text] [Related]

  • 28. Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study.
    Corton JC, Cunningham ML, Hummer BT, Lau C, Meek B, Peters JM, Popp JA, Rhomberg L, Seed J, Klaunig JE.
    Crit Rev Toxicol; 2014 Jan 01; 44(1):1-49. PubMed ID: 24180432
    [Abstract] [Full Text] [Related]

  • 29. Identification of chemical modulators of the constitutive activated receptor (CAR) in a gene expression compendium.
    Oshida K, Vasani N, Jones C, Moore T, Hester S, Nesnow S, Auerbach S, Geter DR, Aleksunes LM, Thomas RS, Applegate D, Klaassen CD, Corton JC.
    Nucl Recept Signal; 2015 Jan 01; 13():e002. PubMed ID: 25949234
    [Abstract] [Full Text] [Related]

  • 30. The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice.
    Su S, Billy LJ, Chang S, Gonzalez FJ, Patterson AD, Peters JM.
    Toxicology; 2022 Jan 15; 465():153056. PubMed ID: 34861291
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Transcription coactivator PRIP, the peroxisome proliferator-activated receptor (PPAR)-interacting protein, is redundant for the function of nuclear receptors PParalpha and CAR, the constitutive androstane receptor, in mouse liver.
    Sarkar J, Qi C, Guo D, Ahmed MR, Jia Y, Usuda N, Viswakarma N, Rao MS, Reddy JK.
    Gene Expr; 2007 Jan 15; 13(4-5):255-69. PubMed ID: 17605299
    [Abstract] [Full Text] [Related]

  • 35. Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression.
    Woods CG, Kosyk O, Bradford BU, Ross PK, Burns AM, Cunningham ML, Qu P, Ibrahim JG, Rusyn I.
    Toxicol Appl Pharmacol; 2007 Dec 15; 225(3):267-77. PubMed ID: 17950772
    [Abstract] [Full Text] [Related]

  • 36. Chemical Activation of the Constitutive Androstane Receptor Leads to Activation of Oxidant-Induced Nrf2.
    Rooney JP, Oshida K, Kumar R, Baldwin WS, Corton JC.
    Toxicol Sci; 2019 Jan 01; 167(1):172-189. PubMed ID: 30203046
    [Abstract] [Full Text] [Related]

  • 37. Hepatic expression of acute-phase protein genes during carcinogenesis induced by peroxisome proliferators.
    Anderson SP, Cattley RC, Corton JC.
    Mol Carcinog; 1999 Dec 01; 26(4):226-38. PubMed ID: 10569800
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Transcriptional activation of PPARalpha by phenobarbital in the absence of CAR and PXR.
    Tamasi V, Juvan P, Beer M, Rozman D, Meyer UA.
    Mol Pharm; 2009 Dec 01; 6(5):1573-81. PubMed ID: 19708687
    [Abstract] [Full Text] [Related]

  • 40. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver.
    Anderson SP, Dunn C, Laughter A, Yoon L, Swanson C, Stulnig TM, Steffensen KR, Chandraratna RA, Gustafsson JA, Corton JC.
    Mol Pharmacol; 2004 Dec 01; 66(6):1440-52. PubMed ID: 15371561
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.